Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GlaxoSmithKline's Consumer Healthcare Unit Reportedly Attracting Private Equity Suitors; Shares Rise Pre-Bell

10/12/2021 | 08:30am EST


ę MT Newswires 2021
All news about GLAXOSMITHKLINE PLC
05:37pUK agrees deals for 114 million more Moderna and Pfizer COVID-19 doses
RE
06:51aGLAXOSMITHKLINE : GSK unveils Target the Future, a global, multi-year programme to help ad..
PU
12:23aBRET TAYLOR : Stocks to Rise After -2-
DJ
11/30Health Care Ticks Down As Sector Seen Resilient to Omicron Fears - Health Care Roundup
DJ
11/30GLAXOSMITHKLINE : Getting ahead of HIV transcript PDF - 192.4KB
PU
11/30GSK Brings In Pfizer Executive As New Head Of Vaccines R&D Unit
MT
11/30GSK Appoints Phil Dormitzer M.D., Ph.D., as Global Head of Vaccines R&D
CI
11/30PFIZER'S DORMITZER LEAVES FOR GLAXOS : Financial Times
MT
11/30GLAXOSMITHKLINE : GSK appoints Phil Dormitzer M.D., Ph.D., as Global Head of Vaccines R&D
PU
11/30GSK names Pfizer scientist Dormitzer as vaccines R&D head
RE
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 843 M 44 917 M 44 917 M
Net income 2021 4 027 M 5 345 M 5 345 M
Net Debt 2021 20 703 M 27 478 M 27 478 M
P/E ratio 2021 19,1x
Yield 2021 5,19%
Capitalization 76 371 M 102 B 101 B
EV / Sales 2021 2,87x
EV / Sales 2022 2,71x
Nbr of Employees 94 066
Free-Float 92,3%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | MarketScreener
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 15,41 GBX
Average target price 1 675,24 GBX
Spread / Average Target 10 770%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC13.64%101 121
JOHNSON & JOHNSON-0.92%410 501
ROCHE HOLDING AG16.39%337 091
PFIZER, INC.45.97%301 579
NOVO NORDISK A/S65.17%243 741
ELI LILLY AND COMPANY46.91%224 871